tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NVCT Stock Latest News

Nuvectis says NXP900 demonstrates robust activity in NSCLC
The FlyNuvectis says NXP900 demonstrates robust activity in NSCLC
18d ago
AZN
NVCT
Nuvectis Pharma’s NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
PremiumPress Releases
Nuvectis Pharma’s NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
18d ago
NVCT
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
PremiumPress Releases
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
1M ago
NVCT
Nuvectis Pharma to Present at the 36th Annual Roth Conference
PremiumPress Releases
Nuvectis Pharma to Present at the 36th Annual Roth Conference
1M ago
NVCT
Nuvectis Pharma Inc trading resumes
PremiumThe Fly
Nuvectis Pharma Inc trading resumes
1M ago
NVCT
Nuvectis Pharma Inc trading halted, volatility trading pause
PremiumThe FlyNuvectis Pharma Inc trading halted, volatility trading pause
1M ago
NVCT
Nuvectis Pharma announces preliminary data from NXP800 Phase 1b trial
PremiumThe Fly
Nuvectis Pharma announces preliminary data from NXP800 Phase 1b trial
1M ago
NVCT
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
PremiumPress Releases
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
1M ago
NVCT
Nuvectis Pharma reports FY23 EPS ($1.43) vs ($1.51) last year
PremiumThe Fly
Nuvectis Pharma reports FY23 EPS ($1.43) vs ($1.51) last year
2M ago
NVCT
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
PremiumPress Releases
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
2M ago
NVCT
NVCT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NVCT Upcoming Earnings Report: What to Expect?
2M ago
NVCT
Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
PremiumPress Releases
Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
3M ago
NVCT
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
PremiumPress ReleasesNuvectis Pharma Announces Participation at Upcoming Investor Conferences
3M ago
NVCT
Nuvectis Pharma enters collaboration with Mayo Clinic to evaluate NXP800
PremiumThe Fly
Nuvectis Pharma enters collaboration with Mayo Clinic to evaluate NXP800
4M ago
NVCT
Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
PremiumPress Releases
Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
6M ago
NVCT
Nuvectis Pharma reports Q3 EPS (37c), consensus (34c)
PremiumThe Fly
Nuvectis Pharma reports Q3 EPS (37c), consensus (34c)
6M ago
NVCT
Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation
PremiumPress Releases
Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation
7M ago
NVCT
Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900
PremiumPress Releases
Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900
7M ago
NVCT
Nuvectis Pharma announces initiation of NXP9000 Phase 1a trial
PremiumThe Fly
Nuvectis Pharma announces initiation of NXP9000 Phase 1a trial
8M ago
NVCT
Nuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900
PremiumPress ReleasesNuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900
8M ago
NVCT
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
PremiumPress Releases
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
8M ago
NVCT
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma
PremiumPress Releases
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma
8M ago
NVCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >